Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211549 · ClinicalTrials.gov registry record · Phase 2
An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee
A Phase 2 study of Osteoarthritis, Knee, sponsored by IDEA.
- Completed
- Registry status
- Phase 2
- Development phase
- 875
- Enrollment target
- 20
- Study locations
NCT00211549: Completed Phase 2 study of Osteoarthritis, Knee, sponsored by IDEA.
NCT00211549 is a Phase 2 study of Osteoarthritis, Knee that has completed, run by IDEA. The registered enrollment target is 875 participants, above the 490-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (79% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00211549, a Phase 2 study of Osteoarthritis, Knee, has completed, sponsored by IDEA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 875 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to identify the dose(s) of IDEA-033 that will provide a meaningful effect for treating osteoarthritis of the knee.
Conditions Studied
Interventions
- DRUG IDEA-033
Study Locations (20)
California
- - Anaheim
- - Encinitas
- - Fair Oaks
- - Garden Grove
- - Irvine
- - Paramount
- - Rancho Mirage
- - San Diego
- - Spring Valley
- - Temecula
- - Vista
Alabama
- - Birmingham
- - Montgomery
- Drug Research and Analysis Corporation - Montgomery
- - Northport
Arizona
- - Mesa
- - Phoenix
- - Tempe
Colorado
- - Northglenn
Connecticut
- - Danbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 875 participants |
| Start Date | 2005-06 |
| Phase | Phase 2 |
What the finished NCT00211549 record still lists
NCT00211549 is an interventional study that assigns participants to a tested intervention. The registered 875 participants enrollment target is mid-sized for trials with a published cap, above the 490-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (79% higher).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which IDEA-033 is the first listed.
NCT00211549 names 20 study sites across 5 states, led by California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00211549 about?
NCT00211549 is a clinical study titled "An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee". The purpose of this study is to identify the dose(s) of IDEA-033 that will provide a meaningful effect for treating osteoarthritis of the knee.
What is the current status of trial NCT00211549?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 875 participants. The study started on 2005-06.
What conditions does trial NCT00211549 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT00211549?
The interventions under investigation include: IDEA-033 (DRUG).
Who is sponsoring clinical trial NCT00211549?
This trial is sponsored by IDEA, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00211549 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00211549's enrollment target sits among peer trials
875 12th of 112 higher than 101 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
RECRUITING · Phase 2
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia